OnKure Therapeutics, Inc. OKUR Business Segments — General Corporate Expenses

Similar metrics at other companies

WLYBResearch — Allocated Corporate expenses

$40.04M+5.3%

RLIGeneral Corporate Expenses

$2.72M-7.6%

CRBGCorporate & Other — General operating expenses

$62M+8.8%

RLMDGeneral and administrative costs

$11.37M+81.5%

CVSCorporate/ Other — Operating expenses, excluding other segment items

$674M+56.0%

AVAHCorporate Expenses

$34.16M-8.9%

Questions, answered.

What is OnKure Therapeutics, Inc.'s business segments — general corporate expenses?

OnKure Therapeutics, Inc. (OKUR) reported business segments — general corporate expenses of $1.18M in Q1 2026.

How has OnKure Therapeutics, Inc.'s business segments — general corporate expenses changed year-over-year?

OnKure Therapeutics, Inc.'s business segments — general corporate expenses decreased by 18.3% year-over-year, from $1.45M to $1.18M.

What does business segments — general corporate expenses mean?

Reflects the portion of general and administrative overhead costs allocated to the clinical research segment to support its operations. These costs cover shared corporate functions such as legal, finance, and human resources that facilitate the research business unit. Tracking this helps identify the burden of corporate overhead on the research segment's financial performance.